Xiaozhong Liao

661 total citations
12 papers, 513 citations indexed

About

Xiaozhong Liao is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Xiaozhong Liao has authored 12 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Xiaozhong Liao's work include Cancer Mechanisms and Therapy (2 papers), Bioactive Natural Diterpenoids Research (2 papers) and Traditional Chinese Medicine Analysis (2 papers). Xiaozhong Liao is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Bioactive Natural Diterpenoids Research (2 papers) and Traditional Chinese Medicine Analysis (2 papers). Xiaozhong Liao collaborates with scholars based in China, United States and Australia. Xiaozhong Liao's co-authors include Jiaxing Zhang, Hanrui Chen, Lingling Sun, Sui-Lin Mo, Lizhu Lin, Yue-Yu Gu, Danlei Chen, Mi Zhou, Ying Gao and Ling Yu and has published in prestigious journals such as Frontiers in Immunology, Molecular Cancer and Cell Death and Disease.

In The Last Decade

Xiaozhong Liao

12 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozhong Liao China 10 340 137 79 70 69 12 513
Mianhua Wu China 14 436 1.3× 172 1.3× 66 0.8× 99 1.4× 67 1.0× 55 680
Jiani Tan China 15 351 1.0× 131 1.0× 60 0.8× 69 1.0× 61 0.9× 29 570
Ling Bi China 14 262 0.8× 100 0.7× 45 0.6× 87 1.2× 88 1.3× 29 569
Su‐Yu Chien Taiwan 17 341 1.0× 126 0.9× 81 1.0× 96 1.4× 58 0.8× 21 640
Hui He China 16 345 1.0× 98 0.7× 37 0.5× 86 1.2× 83 1.2× 30 670
Xianan Sang China 13 294 0.9× 159 1.2× 53 0.7× 51 0.7× 41 0.6× 34 551
Xiumei Gao China 11 329 1.0× 62 0.5× 85 1.1× 94 1.3× 65 0.9× 20 556
Zequn Jiang China 12 281 0.8× 89 0.6× 54 0.7× 62 0.9× 55 0.8× 20 528
Decai Tang China 14 285 0.8× 176 1.3× 87 1.1× 64 0.9× 43 0.6× 25 478
Chuan‐Chou Tu Taiwan 12 329 1.0× 161 1.2× 108 1.4× 168 2.4× 57 0.8× 17 631

Countries citing papers authored by Xiaozhong Liao

Since Specialization
Citations

This map shows the geographic impact of Xiaozhong Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhong Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhong Liao more than expected).

Fields of papers citing papers by Xiaozhong Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhong Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhong Liao. The network helps show where Xiaozhong Liao may publish in the future.

Co-authorship network of co-authors of Xiaozhong Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhong Liao. A scholar is included among the top collaborators of Xiaozhong Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhong Liao. Xiaozhong Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Cen, Junjie, Yanping Liang, Yong Huang, et al.. (2021). Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis. Molecular Cancer. 20(1). 19–19. 85 indexed citations
4.
Chen, Zhiqiang, Tong Lin, Xiaozhong Liao, et al.. (2021). Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma. Chinese Medicine. 16(1). 13–13. 69 indexed citations
5.
Liao, Xiaozhong, Ying Gao, Hongwei Zhao, et al.. (2021). Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway. Frontiers in Cell and Developmental Biology. 8. 609285–609285. 43 indexed citations
6.
Gao, Ying, Danlei Chen, Mi Zhou, et al.. (2020). Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway. Cell Death and Disease. 11(10). 866–866. 29 indexed citations
7.
Liao, Xiaozhong, Wei Guo, Zhuo‐Xun Wu, et al.. (2020). Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway. Frontiers in Oncology. 10. 1732–1732. 15 indexed citations
8.
Liao, Xiaozhong, Ying Gao, Lingling Sun, et al.. (2020). Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway. Phytotherapy Research. 34(5). 1142–1153. 55 indexed citations
9.
10.
Gu, Yue-Yu, Menghua Chen, Brian H. May, et al.. (2018). Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3. Phytomedicine. 51. 214–225. 51 indexed citations
11.
Liao, Xiaozhong, Jiahui Liu, Yue-Yu Gu, et al.. (2017). Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway. Cancer Cell International. 17(1). 124–124. 54 indexed citations
12.
Xie, Jun, Jiahui Liu, Heng Liu, et al.. (2016). Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. BMC Cancer. 16(1). 899–899. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mianhua Wu Breakdown of academic impact, for papers by Jiani Tan Breakdown of academic impact, for papers by Ling Bi Breakdown of academic impact, for papers by Su‐Yu Chien Breakdown of academic impact, for papers by Hui He Breakdown of academic impact, for papers by Xianan Sang Breakdown of academic impact, for papers by Xiumei Gao Breakdown of academic impact, for papers by Zequn Jiang Breakdown of academic impact, for papers by Decai Tang Breakdown of academic impact, for papers by Chuan‐Chou Tu
Rankless by CCL
2026